Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
NCT00003917
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
topotecan hydrochloride
Sponsor
Case Comprehensive Cancer Center
Collaborators
[object Object]